Figure S2. Comorbidity prevalence in main analysis compared with sensitivity analyses. (DOC 104 kb
Table S1. International Classification of Disease (ICD) codes, 10th revision, for classification of ...
List of LUNG SAFE investigators. Names and affiliations of the LUNG SAFE investigators. (PDF 172Â kb
Online supplement (DOC). Figure S1. Histograms showing propensity score distribution. Table S1. Base...
Table S6. Proportion of treated comorbid conditions according to sensitivity analyses. (DOC 60 kb
Table S7. Associations of clinical characteristics and survival within the sensitivity analyses. (DO...
Table S5. Prescription patterns of comorbidity-relevant medication according to sensitivity analyses...
Table S2. Prescription patterns of comorbidity-relevant medication at the subtype level. (DOC 75 kb
Table S4. Baseline characteristics of the study sample within Sensitivity Analysis 2. (DOC 56 kb
Table S3. ILD subtype-specific hazard ratios as per the comorbidity-only Cox model. (DOC 97 kb
Figure S3. Pneumoconios-, Drug-associated ILD-, Radiation-asscociated pneumonitis-, Eosinophilic pne...
Comorbidities among respiratory diseases. Figure S1. Comorbidities* between respiratory diseases and...
Treatment modality in treatment group (nâ=â86). Table S2. Comorbidities of study population. Tab...
Table S1. Ten-Year CVD Risk by GOLD classification and selected baseline characteristics in COPD pat...
BACKGROUND: Interstitial lung diseases (ILDs) are associated with a high burden of disease. However,...
Table S1. Adjusted odds of outcomes, IPF ânarrowâ cohort (ICD9 516.3 only). Results of the sensi...
Table S1. International Classification of Disease (ICD) codes, 10th revision, for classification of ...
List of LUNG SAFE investigators. Names and affiliations of the LUNG SAFE investigators. (PDF 172Â kb
Online supplement (DOC). Figure S1. Histograms showing propensity score distribution. Table S1. Base...
Table S6. Proportion of treated comorbid conditions according to sensitivity analyses. (DOC 60 kb
Table S7. Associations of clinical characteristics and survival within the sensitivity analyses. (DO...
Table S5. Prescription patterns of comorbidity-relevant medication according to sensitivity analyses...
Table S2. Prescription patterns of comorbidity-relevant medication at the subtype level. (DOC 75 kb
Table S4. Baseline characteristics of the study sample within Sensitivity Analysis 2. (DOC 56 kb
Table S3. ILD subtype-specific hazard ratios as per the comorbidity-only Cox model. (DOC 97 kb
Figure S3. Pneumoconios-, Drug-associated ILD-, Radiation-asscociated pneumonitis-, Eosinophilic pne...
Comorbidities among respiratory diseases. Figure S1. Comorbidities* between respiratory diseases and...
Treatment modality in treatment group (nâ=â86). Table S2. Comorbidities of study population. Tab...
Table S1. Ten-Year CVD Risk by GOLD classification and selected baseline characteristics in COPD pat...
BACKGROUND: Interstitial lung diseases (ILDs) are associated with a high burden of disease. However,...
Table S1. Adjusted odds of outcomes, IPF ânarrowâ cohort (ICD9 516.3 only). Results of the sensi...
Table S1. International Classification of Disease (ICD) codes, 10th revision, for classification of ...
List of LUNG SAFE investigators. Names and affiliations of the LUNG SAFE investigators. (PDF 172Â kb
Online supplement (DOC). Figure S1. Histograms showing propensity score distribution. Table S1. Base...
DOI
Add to ORKG